Država: Velika Britanija
Jezik: angleščina
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Cilastatin sodium; Imipenem monohydrate
Fresenius Kabi Ltd
J01DH51
Cilastatin sodium; Imipenem monohydrate
500mg ; 500mg
Powder for solution for infusion
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010202; GTIN: 05018750179995